KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: GBM Agile Update, page-56

  1. 16,632 Posts.
    lightbulb Created with Sketch. 2371
    Well they still have another Paxalisib trial in play and the other cancer treatment under test.
    And the final analysis of the trial might reveal how close it was to success and perhaps some other clues.
    But right now it has no chance of FDA approval for GBM.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.